A series of homeopathic remedies-related severe drug-induced liver injury from South India.


Journal

Hepatology communications
ISSN: 2471-254X
Titre abrégé: Hepatol Commun
Pays: United States
ID NLM: 101695860

Informations de publication

Date de publication:
01 03 2023
Historique:
received: 16 10 2022
accepted: 10 12 2022
entrez: 9 2 2023
pubmed: 10 2 2023
medline: 14 2 2023
Statut: epublish

Résumé

Homeopathic remedies are highly diluted formulations without proven clinical benefits, traditionally believed not to cause adverse events. Nonetheless, published literature reveals severe local and non-liver-related systemic side effects. We present the first series on homeopathy-related severe drug-induced liver injury (DILI) from a single center. A retrospective review of records from January 2019 to February 2022 identified 9 patients with liver injury attributed to homeopathic formulations. Competing causes were comprehensively excluded. Chemical analysis was performed on retrieved formulations using triple quadrupole gas chromatography-mass spectrometry and inductively coupled plasma atomic emission spectroscopy. Males predominated with a median age of 54 years. The most typical clinical presentation was acute hepatitis, followed by acute on chronic liver failure. All patients developed jaundice, and ascites were notable in one-third of the patients. Five patients had underlying chronic liver disease. COVID-19 prevention was the most common indication for homeopathic use. Probable DILI was seen in 77.8%, and hepatocellular injury predominated (66.7%). Four (44.4%) patients died (3 with chronic liver disease) at a median follow-up of 194 days. Liver histopathology showed necrosis, portal and lobular neutrophilic inflammation, and eosinophilic infiltration with cholestasis. A total of 29 remedies were consumed between 9 patients, and 15 formulations were analyzed. Toxicology revealed industrial solvents, corticosteroids, antibiotics, sedatives, synthetic opioids, heavy metals, and toxic phyto-compounds, even in 'supposed' ultra-dilute formulations. Homeopathic remedies potentially result in severe liver injury, leading to death in those with underlying liver disease. The use of mother tinctures, insufficient dilution, poor manufacturing practices, adulteration and contamination, and the presence of direct hepatotoxic herbals were the reasons for toxicity. Physicians, the public, and patients must realize that Homeopathic drugs are not 'gentle placebos.'

Identifiants

pubmed: 36757412
doi: 10.1097/HC9.0000000000000064
pii: 02009842-202303010-00010
pmc: PMC9916127
doi:

Substances chimiques

Materia Medica 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0064

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases.

Références

World J Hepatol. 2013 May 27;5(5):251-63
pubmed: 23717736
Hepatol Commun. 2022 Jun;6(6):1289-1300
pubmed: 35037744
J Hepatol. 2020 Oct;73(4):842-854
pubmed: 32673741
Ann Hepatol. 2015 Jan-Feb;14(1):7-19
pubmed: 25536637
Int J Mol Sci. 2015 Dec 24;17(1):
pubmed: 26712744
EMBO Rep. 2019 Mar;20(3):
pubmed: 30765373
Front Pharmacol. 2021 Apr 13;12:643972
pubmed: 33927623
Clin Gastroenterol Hepatol. 2010 May;8(5):463-70
pubmed: 20170750
Hepatol Int. 2019 Jul;13(4):353-390
pubmed: 31172417
Am J Gastroenterol. 2017 Sep;112(9):1389-1396
pubmed: 28440304
Int J Clin Pract. 2013 Apr;67(4):386-7
pubmed: 23521333
J Clin Epidemiol. 1993 Nov;46(11):1323-30
pubmed: 8229110
Exp Suppl. 2012;101:133-64
pubmed: 22945569
J Clin Transl Hepatol. 2019 Sep 28;7(3):263-274
pubmed: 31608219
Eur J Clin Pharmacol. 2013 Mar;69(3):295-307
pubmed: 22843016
Int J Mol Sci. 2020 Jul 16;21(14):
pubmed: 32708570
Int J Clin Pract. 2012 Dec;66(12):1178-88
pubmed: 23163497
Hepatology. 2017 Aug;66(2):646-654
pubmed: 28295448
Gastroenterol Rep (Oxf). 2017 May;5(2):138-147
pubmed: 28533911
Wien Klin Wochenschr. 2020 May;132(9-10):232-242
pubmed: 32152694
World J Gastroenterol. 2012 Jun 14;18(22):2756-66
pubmed: 22719183
Explore (NY). 2022 Jan-Feb;18(1):114-128
pubmed: 33303386
World J Hepatol. 2020 Sep 27;12(9):574-595
pubmed: 33033566
Indian J Gastroenterol. 2018 Jan;37(1):9-17
pubmed: 29476406
Expert Rev Gastroenterol Hepatol. 2018 Apr;12(4):425-434
pubmed: 29323538
Lancet. 1987 Mar 14;1(8533):635
pubmed: 2881175
J Clin Pathol. 2009 Jun;62(6):481-92
pubmed: 19474352

Auteurs

Arif Hussain Theruvath (AH)

Division of Complementary and Alternative Medicine (Homoeopathy), Department of Clinical Research, The Liver Institute, Center for Excellence in Gastrointestinal Sciences, Rajagiri Hospital, Aluva, Kerala, India.

Resmi Raveendran (R)

Division of Complementary and Alternative Medicine (Ayurveda), Department of Clinical Research, The Liver Institute, Center for Excellence in Gastrointestinal Sciences, Rajagiri Hospital, Aluva, Kerala, India.

Cyriac Abby Philips (CA)

Clinical and Translational Hepatology & Monarch Liver Laboratory, The Liver Institute, Center for Excellence in Gastrointestinal Sciences, Rajagiri Hospital, Aluva, Kerala, India.

Rizwan Ahamed (R)

Gastroenterology and Advanced GI Endoscopy, Center of Excellence in GI Sciences, Rajagiri Hospital, Chunangamvely, Aluva, Kerala, India.

Jinsha K Abduljaleel (JK)

Gastroenterology and Advanced GI Endoscopy, Center of Excellence in GI Sciences, Rajagiri Hospital, Chunangamvely, Aluva, Kerala, India.

Ajit Tharakan (A)

Gastroenterology and Advanced GI Endoscopy, Center of Excellence in GI Sciences, Rajagiri Hospital, Chunangamvely, Aluva, Kerala, India.

Sasidharan Rajesh (S)

Interventional Hepatobiliary Radiology, The Liver Institute, Center of Excellence in GI Sciences, Rajagiri Hospital, Chunangamvely, Aluva, Kerala, India.

Philip Augustine (P)

Gastroenterology and Advanced GI Endoscopy, Center of Excellence in GI Sciences, Rajagiri Hospital, Chunangamvely, Aluva, Kerala, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH